REGENXBIO, Inc. (RGNX)
6.68
-0.49
(-6.83%)
USD |
NASDAQ |
Oct 23, 16:00
6.67
-0.01
(-0.15%)
Pre-Market: 20:00
REGENXBIO Market Cap : 361.82M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 361.82M |
| October 22, 2026 | 388.36M |
| October 21, 2026 | 388.36M |
| October 20, 2026 | 400.81M |
| October 19, 2026 | 387.27M |
| October 16, 2026 | 375.09M |
| October 15, 2026 | 387.81M |
| October 14, 2026 | 372.65M |
| October 13, 2026 | 393.23M |
| October 12, 2026 | 420.85M |
| October 09, 2026 | 437.10M |
| October 08, 2026 | 438.19M |
| October 07, 2026 | 411.38M |
| October 06, 2026 | 403.52M |
| October 05, 2026 | 420.31M |
| October 02, 2026 | 402.44M |
| October 01, 2026 | 401.90M |
| September 30, 2026 | 407.85M |
| September 29, 2026 | 403.52M |
| September 28, 2026 | 404.61M |
| September 25, 2026 | 400.81M |
| September 24, 2026 | 392.15M |
| September 23, 2026 | 406.23M |
| September 22, 2026 | 441.44M |
| September 21, 2026 | 426.81M |
| Date | Value |
|---|---|
| September 18, 2026 | 434.94M |
| September 17, 2026 | 444.96M |
| September 16, 2026 | 432.23M |
| September 15, 2026 | 430.33M |
| September 14, 2026 | 470.69M |
| September 11, 2026 | 462.02M |
| September 10, 2026 | 463.64M |
| September 09, 2026 | 472.85M |
| September 08, 2026 | 474.48M |
| September 04, 2026 | 484.23M |
| September 03, 2026 | 498.31M |
| September 02, 2026 | 519.97M |
| September 01, 2026 | 504.81M |
| August 31, 2026 | 514.56M |
| August 28, 2026 | 523.22M |
| August 27, 2026 | 507.52M |
| August 26, 2026 | 508.06M |
| August 25, 2026 | 482.60M |
| August 24, 2026 | 436.29M |
| August 21, 2026 | 580.64M |
| August 20, 2026 | 599.05M |
| August 19, 2026 | 651.05M |
| August 18, 2026 | 599.60M |
| August 17, 2026 | 613.68M |
| August 14, 2026 | 583.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 504.75B |
| United Therapeutics Corp. | 25.07B |
| Biomea Fusion, Inc. | 43.50M |
| RenovoRx, Inc. | 58.21M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| PS Ratio | 1.999 |
| PEG Ratio | -0.1907 |
| Price to Book Value | 5.042 |
| Price | 6.68 |
| Earnings Yield | -56.66% |
| PEGY Ratio | -0.1907 |